Susquehanna International Group, LLP Iridex Corp Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Iridex Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 30,869 shares of IRIX stock, worth $39,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,869

Previous 65,393 52.79%

Holding current value

$39,821

Previous $114,000 54.39%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	SELL	$1.39 - $1.93 $47,988 - $66,631	-34,524 Reduced 52.79%	30,869 $52,000
Q3 2024 Nov 14, 2024	BUY	$1.75 - $2.15 $7,927 - $9,739	4,530 Added 7.44%	65,393 $114,000
Q2 2024 Aug 15, 2024	SELL	$1.97 - $3.53 $48,284 - $86,520	-24,510 Reduced 28.71%	60,863 $131,000
Q1 2024 May 07, 2024	SELL	$2.35 - $3.1 $48,699 - $64,241	-20,723 Reduced 19.53%	85,373 $254,000
Q4 2023 Feb 14, 2024	BUY	$1.9 - $3.28 $102,525 - $176,992	53,961 Added 103.5%	106,096 $298,000
Q3 2023 Nov 14, 2023	BUY	$1.33 - $2.54 $69,339 - $132,422	52,135 New	52,135 $132,000
Q1 2023 May 16, 2023	BUY	$2.0 - $2.46 $20,188 - $24,831	10,094 New	10,094 $20,000
Q2 2022 Aug 15, 2022	BUY	$2.48 - $4.66 $32,872 - $61,768	13,255 Added 116.7%	24,613 $63,000
Q1 2022 May 16, 2022	BUY	$3.99 - $6.42 $3,678 - $5,919	922 Added 8.83%	11,358 $53,000
Q4 2021 Feb 14, 2022	SELL	$5.62 - $9.37 $2,736 - $4,563	-487 Reduced 4.46%	10,436 $64,000
Q3 2021 Nov 15, 2021	BUY	$6.29 - $7.98 $68,705 - $87,165	10,923 New	10,923 $84,000

Others Institutions Holding IRIX

# of Institutions

Shares Held

3.2M

Call Options Held

Put Options Held

4.4K

View Full List

About IRIDEX CORP

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $20.6M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

More about IRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Iridex Corp Transaction History